Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 3—March 2018
Dispatch

Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014–2015

Maite AubryComments to Author , Anita Teissier, Michael Huart, Sébastien Merceron, Jessica Vanhomwegen, Mihiau Mapotoeke, Teheipuaura Mariteragi-Helle, Claudine Roche, Anne-Laure Vial, Sylvianne Teururai, Sébastien Sicard, Sylvie Paulous, Philippe Desprès, Jean-Claude Manuguerra, Henri-Pierre Mallet, Allison Imrie, Didier Musso, Xavier Deparis, and Van-Mai Cao-Lormeau
Author affiliations: Aix Marseille University, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France (M. Aubry, A. Teissier, T. Mariteragi-Helle, S. Teururai, D. Musso, V.-M. Cao-Lormeau); Institut Louis Malardé, Papeete, French Polynesia (M. Aubry, A. Teissier, M. Mapotoeke, T. Mariteragi-Helle, C. Roche, S. Teururai, D. Musso, V.-M. Cao-Lormeau); Centre d’Épidémiologie et de Santé Publique des Armées, Marseille, France, and Unité Mixte de Recherche Sciences Economiques et Sociales de la Santé et Traitement de l'Information Médicale, Marseille (M. Huart, S. Sicard, X. Deparis); Institut de la Statistique de la Polynésie Française, Papeete, and Institut National de la Statistique et des Études Économiques, Sainte Clotilde, La Réunion (S. Merceron); Institut Pasteur, Paris, France (J. Vanhomwegen, S. Paulous, J.-C. Manuguerra); Direction de la Santé de la Polynésie Française, Papeete (M. Mapotoeke, A.-L. Vial, H.-P. Mallet); Direction Départementale de la Cohésion Sociale et de la Protection des Populations, Yonne, France (A.-L. Vial); Université de la Réunion, Sainte Clotilde (P. Desprès); University of Western Australia, Perth, Western Australia, Australia (A. Imrie)

Main Article

Table 1

Seropositivity for antibodies against dengue and chikungunya viruses among participants randomly recruited, French Polynesia, 2014–2015*

General population, Feb–Mar 2014 Schoolchildren, May–Jun 2014, Society, n = 476 General population, Sep–Nov 2015, Society, n = 700
Society, n = 49
 Tuamotu, n = 49
 Marquesas, n = 49
 Austral –Gambier, n = 49
 Total, n = 196
Dengue
>1 type 46 (94 ± 8) 49 (100 ± 0) 46 (94 ± 8) 47 (96 ± 6) 188 (96 ± 3) 285 (60 ± 5) 582 (83 ± 3)
Type 1 42 (86 ± 16) 47 (96 ± 5) 41 (84 ± 13) 42 (86 ± 11) 172 (88 ± 6) 239 (50 ± 5) 562 (80 ± 4)
Type 2 23 (47 ± 17) 22 (45 ± 13) 26 (53 ± 12) 28 (57 ± 12) 99 (51 ± 7) 0 127 (18 ± 4)
Type 3 37 (76 ± 18) 33 (67 ± 21) 35 (71 ± 14) 26 (53 ± 15) 131 (67 ± 9) 72 (15 ± 3) 384 (55 ± 4)
Type 4 31 (63 ± 8) 32 (65 ± 21) 29 (59 ± 15) 27 (55 ± 15) 119 (61 ± 8) 69 (14 ± 3) 293 (42 ± 7)
Asymptomatic
 36/46 (78 ± 12)
 29/49 (59 ± 14)
 24/46 (52 ± 14)
 34/47 (72 ± 13)
 123/188 (65 ± 7)
 230/285 (81 ± 5)
 299/582 (51 ± 4)
Chikungunya 3 (6 ± 8) 1 (2 ± 4) 1 (2 ± 4) 1 (2 ± 4) 6 (3 ± 3) 2 (1 ± 1) 529 (76 ± 5)
Asymptomatic ND ND ND ND ND ND 70/529 (13 ± 2)

*95% CIs were calculated by taking into account the cluster sampling design and using the Fisher exact test. Median ages of participants among the general population, 38–47 y; of schoolchildren, 11 y. ND, not determined.

Main Article

Page created: February 16, 2018
Page updated: February 16, 2018
Page reviewed: February 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external